SMC HEALTHCARE

Specialized Medical Company

4019StocksTadawulHealthcare

Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	3.88B	4.51B	—	—	—
Enterprise Value	4.60B	5.12B	—	—	—
Last Close Price	15.53	16.92	—	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	15.35	14.35	—	—	—
PE Ratio	14.43	16.94	—	—	—
PEG Ratio	1.54	0.80	—	—	—
PS Ratio	2.50	2.93	—	—	—
PB Ratio	3.81	3.80	—	—	—
P/TBV Ratio	3.81	3.80	—	—	—
P/FCF Ratio	19.43	19.76	—	—	—
P/OCF Ratio	13.49	13.97	—	—	—
EV/Sales Ratio	2.97	3.33	—	—	—
EV/EBITDA Ratio	13.88	17.23	—	—	—
EV/EBIT Ratio	19.53	21.81	—	—	—
EV/FCF Ratio	23.01	22.45	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.81	0.70	1.04	1.02	1.11
Debt / EBITDA Ratio	2.50	2.52	2.71	2.85	3.52
Debt / FCF Ratio	4.14	3.62	2.98	5.37	6.99
Net Debt / Equity Ratio	0.70	0.49	0.93	0.96	1.08
Net Debt / EBITDA Ratio	2.39	1.94	2.67	2.98	3.92
Net Debt / FCF Ratio	3.58	2.53	2.66	5.07	6.80
Efficiency & Liquidity
Asset Turnover	0.71	0.69	0.70	0.69	0.65
Inventory Turnover	39.29	46.35	44.21	44.30	47.31
Quick Ratio	0.95	1.30	0.67	0.79	0.70
Current Ratio	1.10	1.42	0.76	0.87	0.76
Returns & Yields
Return on Equity (ROE)	+28.7%	+26.4%	+22.2%	+21.4%	+14.5%
Return on Assets (ROA)	+6.7%	+6.6%	+7.0%	+6.8%	+4.3%
Return on Invested Capital (ROIC)	+13.2%	+13.7%	+13.5%	+13.0%	+8.1%
Return on Capital Employed (ROCE)	+14.2%	+12.7%	+18.1%	+15.7%	+10.3%
Earnings Yield	+6.9%	+5.9%	—	—	—
FCF Yield	+5.1%	+5.1%	—	—	—
Dividend Yield	+2.1%	+1.9%	—	—	—
Payout Ratio	+74.3%	—	+108.0%	+35.6%	+48.6%
Buyback Yield / Dilution	—	—	-194.1%	—	—
Total Shareholder Return	+2.1%	+1.9%	-194.1%	—	—

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	3.88B	4.51B	—	—	—
Enterprise Value	4.60B	5.12B	—	—	—
Last Close Price	15.53	16.92	—	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	15.35	14.35	—	—	—
PE Ratio	14.43	16.94	—	—	—
PEG Ratio	1.54	0.80	—	—	—
PS Ratio	2.50	2.93	—	—	—
PB Ratio	3.81	3.80	—	—	—
P/TBV Ratio	3.81	3.80	—	—	—
P/FCF Ratio	19.43	19.76	—	—	—
P/OCF Ratio	13.49	13.97	—	—	—
EV/Sales Ratio	2.97	3.33	—	—	—
EV/EBITDA Ratio	13.88	17.23	—	—	—
EV/EBIT Ratio	19.53	21.81	—	—	—
EV/FCF Ratio	23.01	22.45	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.81	0.70	1.04	1.02	1.11
Debt / EBITDA Ratio	2.50	2.52	2.71	2.85	3.52
Debt / FCF Ratio	4.14	3.62	2.98	5.37	6.99
Net Debt / Equity Ratio	0.70	0.49	0.93	0.96	1.08
Net Debt / EBITDA Ratio	2.39	1.94	2.67	2.98	3.92
Net Debt / FCF Ratio	3.58	2.53	2.66	5.07	6.80
Efficiency & Liquidity
Asset Turnover	0.71	0.69	0.70	0.69	0.65
Inventory Turnover	39.29	46.35	44.21	44.30	47.31
Quick Ratio	0.95	1.30	0.67	0.79	0.70
Current Ratio	1.10	1.42	0.76	0.87	0.76
Returns & Yields
Return on Equity (ROE)	+28.7%	+26.4%	+22.2%	+21.4%	+14.5%
Return on Assets (ROA)	+6.7%	+6.6%	+7.0%	+6.8%	+4.3%
Return on Invested Capital (ROIC)	+13.2%	+13.7%	+13.5%	+13.0%	+8.1%
Return on Capital Employed (ROCE)	+14.2%	+12.7%	+18.1%	+15.7%	+10.3%
Earnings Yield	+6.9%	+5.9%	—	—	—
FCF Yield	+5.1%	+5.1%	—	—	—
Dividend Yield	+2.1%	+1.9%	—	—	—
Payout Ratio	+74.3%	—	+108.0%	+35.6%	+48.6%
Buyback Yield / Dilution	—	—	-194.1%	—	—
Total Shareholder Return	+2.1%	+1.9%	-194.1%	—	—